10071287

Source:http://linkedlifedata.com/resource/pubmed/id/10071287

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0205225, umls-concept:C0282460, umls-concept:C0332283, umls-concept:C0851346, umls-concept:C1332880
pubmed:issue	3
pubmed:dateCreated	1999-3-16
pubmed:abstractText	A prospective phase II study was initiated to assess the response rate, survival, and late effects of treatment in patients with newly diagnosed CNS germ cell tumors (GCT), using etoposide plus cisplatin followed by radiation therapy prescribed by extent of disease, histology, and response to chemotherapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA 15083
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Chorionic Gonadotropin, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0732-183X
pubmed:author	pubmed-author:BucknerJ CJC, pubmed-author:GrooverR VRV, pubmed-author:KimmelD WDW, pubmed-author:NegliaJJ, pubmed-author:O'FallonJ RJR, pubmed-author:PeethambaramP PPP, pubmed-author:RaffelCC, pubmed-author:SchombergP JPJ, pubmed-author:ShawE GEG, pubmed-author:SmithsonW AWA
pubmed:issnType	Print
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	933-40
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:10071287-Adolescent, pubmed-meshheading:10071287-Adult, pubmed-meshheading:10071287-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10071287-Central Nervous System Neoplasms, pubmed-meshheading:10071287-Child, pubmed-meshheading:10071287-Chorionic Gonadotropin, pubmed-meshheading:10071287-Cisplatin, pubmed-meshheading:10071287-Combined Modality Therapy, pubmed-meshheading:10071287-Etoposide, pubmed-meshheading:10071287-Female, pubmed-meshheading:10071287-Germinoma, pubmed-meshheading:10071287-Hematologic Diseases, pubmed-meshheading:10071287-Humans, pubmed-meshheading:10071287-Male, pubmed-meshheading:10071287-Prospective Studies, pubmed-meshheading:10071287-Radiotherapy Dosage, pubmed-meshheading:10071287-Remission Induction, pubmed-meshheading:10071287-Vomiting, pubmed-meshheading:10071287-alpha-Fetoproteins
pubmed:year	1999
pubmed:articleTitle	Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
pubmed:affiliation	Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. buckner.jan@mayo.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase II